Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07079306 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ChatGPT-Supported Text Messaging Program for Smoking Cessation

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Dec 30, 2026 → Mar 30, 2027
See other at-risk trials from George Washington University

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fields
  2. Minor Primary completion pushed from Dec 30, 2026 to Mar 30, 2027 Show 4 more changesShow less
    • Enrollment increased: 150 → 180 participants
    • Study completion pushed from Jan 30, 2027 to Oct 30, 2027
    • Start date: Oct 1, 2026 to Oct 2026
    • Eligibility criteria expanded, about 20 words
  3. Notable Primary completion date: Dec 30, 2025 to Dec 30, 2026
    • Start date: Oct 1, 2025 to Oct 1, 2026
    • Study completion date: Jan 30, 2026 to Jan 30, 2027
    v5
  4. Notable Start date: Aug 30, 2025 to Oct 1, 2025v4 Show 4 more changesShow less
    • Primary endpoint revised
    • Study sites: 0 to 1
    • Primary completion date: Oct 30, 2025 to Dec 30, 2025
    • Study completion date: Oct 30, 2025 to Jan 30, 2026
  5. Notable Start date: Jul 21, 2025 to Aug 30, 2025
    • Primary and study completion dates: Sep 30, 2025 to Oct 30, 2025
    v3
  6. Notable Primary endpoint revised
    • Eligibility criteria shortened, about 3 words
    v2
  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The current research proposal aims to explore how a purpose driven LLM ChatGPT chatbot, BeFreeBot, might enhance an evidence-based text messaging smoking cessation program, BeFree. The research will consist of a formative evaluation comparing quitting related outcomes among users of BeFree+Bot and BeFree.
Trial Details
NCT Number NCT07079306
Lead Sponsor George Washington University
Conditions
(from sponsor)
Smoking Cessation
Related terms Smoking Cessation
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov